Package 50090-1042-0
Brand: amlodipine and benazepril hydrochloride
Generic: amlodipine and benazepril hydrochloridePackage Facts
Identity
Package NDC
50090-1042-0
Digits Only
5009010420
Product NDC
50090-1042
Description
30 CAPSULE in 1 BOTTLE (50090-1042-0)
Marketing
Marketing Status
Brand
amlodipine and benazepril hydrochloride
Generic
amlodipine and benazepril hydrochloride
Sample Package
No
Linked Drug Pages (0)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "aa9fc6df-5e9e-46cd-8600-e60b5f4a1dfe", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898356"], "spl_set_id": ["f77db79c-c998-4b63-9984-4cf245f188a7"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-1042-0)", "package_ndc": "50090-1042-0", "marketing_start_date": "20141128"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (50090-1042-1)", "package_ndc": "50090-1042-1", "marketing_start_date": "20141128"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "50090-1042_aa9fc6df-5e9e-46cd-8600-e60b5f4a1dfe", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "50090-1042", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20120905", "listing_expiration_date": "20261231"}